ArticleAIDS (London, England)2021

Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV.

Jake A Ruddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.